Joel S. Schuman

Joel S. Schuman, MD, FACS, Professor and Chairman of Ophthalmology

Joel S. Schuman is an American ophthalmologist, specialising in glaucoma. In 2016 he was appointed Director of NYU Langone Eye Center and Professor and Chairman of Ophthalmology at NYU Langone Medical Center, NYU School of Medicine, and Professor of Electrical and Computer Engineering at NYU Tandon School of Engineering. In 2016 he was also appointed Professor of Neuroscience and Physiology and a member of the Neuroscience Institute, at NYU Langone Medical Center, NYU School of Medicine. From 2003 - 2016 he was the Professor and Chairman of Ophthalmology at the Eye and Ear Institute, University of Pittsburgh School of Medicine, the Eye and Ear Foundation Endowed Chair and Director of the University of Pittsburgh Medical Center (UPMC) Eye Center. He was also Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh and Director of the Louis J. Fox Center for Vision Restoration of UPMC and the University of Pittsburgh.[1] He was a member of the McGowan Institute for Regenerative Medicine and the Center for the Neural Basis of Cognition, Carnegie Mellon University and University of Pittsburgh. He became a Distinguished Professor of Ophthalmology at the University of Pittsburgh in September 2014.[2]

Research

Dr. Schuman and his colleagues were the first to identify a molecular marker for human glaucoma. This discovery was published in Nature Medicine in 2001.[3] The National Eye Institute has funded Schuman as a principal investigator since 1995.

Joel Schuman, along with Eric Swanson, James Fujimoto, Carmen Puliafito, Charles Lin and David Huang, invented the optical coherence tomography (OCT) technology. This technology, allows a quick and noninvasive 3D map of the eye, in particular the retina. It is one of the tools available for early detection of eye diseases such as glaucoma, along with macular degeneration and diabetic retinopathy. More than 60,000 of these machines are used daily throughout the world.[4][5][6]

Awards and nominations

He received the Champalimaud Award, which includes a monetary award of $1 million euros.[7]

Biography

Schuman is a native of Roslyn, NY. He graduated from Columbia University (AB, 1980) and Mt. Sinai School of Medicine (MD, 1984). Following internship at New York’s Beth Israel Medical Center (1985), he completed residency training at Medical College of Virginia (1988) and glaucoma fellowship at Massachusetts Eye & Ear Infirmary (clinical 1989, research 1990), where he was a Heed fellow. After just over a year on the Harvard faculty, he moved to New England Medical Center, Tufts University to co-found New England Eye Center in 1991, where he was Residency Director and Glaucoma and Cataract Service Chief. In 1998 he became Professor of Ophthalmology, and Vice Chair in 2001. He is married and has three children. His wife, Carole, is a lawyer, and his children are Alexandra, in business, Eric, a film writer, cinematographer and director, and Ari, in medicine.

References

  1. "Department of Ophthalmology". Ophthalmology.medicine.pitt.edu. Retrieved 2015-08-29.
  2. "Pitt Faculty Members Awarded Distinguished Professorships | Pitt Chronicle | University of Pittsburgh". Chronicle.pitt.edu. 2014-09-08. Retrieved 2015-08-29.
  3. "Press Releases - Nature Medicine". Nature.com. Retrieved 2015-08-29.
  4. "Disclosures" (PDF). Fda.gov. Retrieved 2015-08-29.
  5. "Articles that mention Joel S. Schuman -Optical Coherence Tomography News". Octnews.org. Retrieved 2015-08-29.
  6. "Sight + Sound" (PDF). Eyeabdear.org. 2012. Retrieved 2015-08-29.
  7. "2012". Fchampalimaud.org. Retrieved 2015-08-29.
This article is issued from Wikipedia - version of the 12/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.